Magnesium hydride-induced hydrogen therapy for enhanced sonodynamic therapy.
Jing Huang, Jianping Meng, Yijie Fan, Engui Wang, Xiangxiang Wang, Huirun Fan, Dan Luo, Lingling Xu, Zhou Li · Materials horizons · 2025
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In the CT26 tumor model, the synergistic combination of SDT and MgH2 therapy significantly enhances the anti-tumor efficacy of SDT compared to that of BTO alone, leading to prolonged survival of treated mice. These findings from a laboratory model add evidence supporting molecular hydrogen's biological and therapeutic potential in the model studied.
What the Findings Mean
H2HUBB reviewed how molecular hydrogen affected the outcomes measured in Moreover, MgH2 upregulates PD-1 expression in T cells, markedly improving the sensitivity of tumors to aPD-1 therapy. In the CT26 tumor model, the synergistic combination of SDT and MgH2 therapy significantly enhances the anti-tumor efficacy of SDT compared to that of BTO alone, leading to prolonged survival of treated mice.
What the Researchers Studied
The researchers studied Moreover, MgH2 upregulates PD-1 expression in T cells, markedly improving the sensitivity of tumors to aPD-1 therapy. The study used a in vitro cell-culture laboratory experiment.
What Effects Did Molecular Hydrogen Have?
Herein, the researchers propose that magnesium hydride (MgH2)-induced hydrogen (H₂) therapy can synergistically enhance barium titanate (BTO)-mediated sonodynamic therapy (SDT) while modulating the TME to improve the efficacy of immune checkpoint inhibitors (aPD-1). In the CT26 tumor model, the synergistic combination of SDT and MgH2 therapy significantly enhances the anti-tumor efficacy of SDT compared to that of BTO alone, leading to prolonged survival of treated mice.
Why These Findings Matter
These findings from a laboratory model add evidence supporting molecular hydrogen's biological and therapeutic potential in the model studied.
How Strong Is This Evidence?
This is laboratory evidence from a in vitro cell-culture laboratory experiment. It is most informative for the biological mechanisms, cellular responses, or biochemical outcomes directly measured.
Technical Study Details
H2HUBB classifies this publication as laboratory study with laboratory or cellular evidence. The research population or model was Moreover, MgH2 upregulates PD-1 expression in T cells, markedly improving the sensitivity of tumors to aPD-1 therapy. The study used a in vitro cell-culture laboratory experiment.
Limitations and Safety
No separate limitations or safety findings were identified in the source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.